GNLX

2.1704.82%
MP

Matthew Pulisic

CFO and Principal Financial & Accounting Officer

Mr. Matthew Pulisic, also known as Matt, M.B.A., is Chief Financial Officer and Principal Financial & Accounting Officer of Genelux Corporation from January 30, 2025. Mr. Pulisic is an accomplished, senior executive with over 19 years of finance and commercial experience in the biopharmaceutical industry, having worked across the United States, Europe and Asia. He is recognized for his expertise in financial leadership, corporate strategy and operational execution. Most recently, Mr. Pulisic served as Vice President of Finance at Arrowhead Pharmaceuticals, a publicly traded RNAi technology company from August 2020 to January 2025. Prior to that, Mr. Pulisic served as Head of Finance for Global Product Development, R&D, Global Marketing & Sourcing at HARMAN International, from August 2019 to August 2020. He played a key role in shaping the company's financial direction, leading planning and analysis, establishing a commercial manufacturing facility and driving operational improvements to support the company's evolution from a clinical-stage to a pre-commercial organization. He began his career at Amgen, a publicly traded commercial biotechnology company, as a Research Associate and transitioned into finance where he held positions of increasing responsibility, across a breadth of finance-related positions, including Finance Director of Amgen Worldwide and Head of Capital Finance. He graduated from California Lutheran University with his M.B.A. in finance and from the University of California, Santa Cruz with his B.S. in Biochemistry and Molecular Biology.

Positions